Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram

Ayse Irem Yasin1, Mahmut Uluganyan2, Zehra Sucuoglu Isleyen3

  • 1Department of Medical Oncology, Bezmialem Vakıf University, Huzur Mah. Cumhuriyet Cad., 34396, Istanbul, Turkey. ayseiremyasin@gmail.com.

Insights

Ribociclib, a breast cancer treatment, shows a low risk of early heart problems. A study using Holter ECG monitoring found no significant cardiac rhythm changes in patients after three months of treatment.

Area of Science:

  • Cardiology
  • Oncology
  • Pharmacology

Background:

  • Ribociclib is a targeted therapy used for metastatic breast cancer.
  • Assessing the cardiac safety of oncology drugs is crucial for patient management.

Purpose of the Study:

  • To evaluate the cardiac safety profile of ribociclib using 24-hour Holter electrocardiogram (ECG).
  • To determine if ribociclib treatment affects cardiac rhythm in breast cancer patients.

Main Methods:

  • The study included 42 female metastatic breast cancer patients.
  • Rhythm Holter ECGs were performed before treatment and after three months of ribociclib initiation.
  • Patients received ribociclib in combination with fulvestrant or aromatase inhibitors.

Main Results:

  • No instances of cardiotoxicity were observed in any patients.
  • Comparison of Holter ECG results before and after three months showed no statistically significant differences in cardiac rhythm.
  • The mean age of the patient cohort was 56.36 ± 12.73 years.

Conclusions:

  • This study provides the first evaluation of ribociclib's cardiac rhythm effects using Holter ECG.
  • Findings suggest that ribociclib has a low risk of causing early cardiotoxicity.
  • Ribociclib can be considered safe regarding cardiac rhythm in the early stages of treatment.
Abstract

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
782
Correlation between ECG and Cardiac Cycle01:25

Correlation between ECG and Cardiac Cycle

The electrical signals recorded on an electrocardiogram (ECG) occur before the mechanical processes of contraction and relaxation during the cardiac cycle.
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
4.1K
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
2.3K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
3.0K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
733
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
932